In this article
Obagi’s Clear naming can make two different products look like interchangeable versions of one purchase. The Nu-Derm Rx record describes hydroquinone, while Clear Fx is marketed as a non-hydroquinone option containing arbutin. A shopper needs to settle that identity question before using a review, price or ingredient claim to make a decision.
We checked the official US Rx information and Clear Fx product page on October 14, 2026, alongside FDA guidance on cosmetic claims. The Fx page displayed $125. A current prescription Clear Rx total was not established. This is a public-record comparison, without a clinical consultation, purchase or product-use test.
Start with the full suffix on the product name
The Rx information describes a four-percent hydroquinone product. The Fx listing concerns a different, non-hydroquinone formula built around arbutin. Omitting those final letters in a shopping note can connect the ingredient list from one product with the price or route of the other. Record the full name before comparing either one. Source 1 Source 2
Our hydroquinone guide gives context for the prescription ingredient, but it does not make Clear Fx a hydroquinone treatment. Conversely, a retail cosmetic listing does not establish the exact product a clinician would prescribe or the label a pharmacy would supply.
A shared brand does not make the formulas substitutes
Hydroquinone and arbutin are different ingredient declarations. The fact that both products are discussed within a dark-spot range does not establish an equivalent effect, matching suitability or permission to switch between them within an existing plan. This review did not evaluate a head-to-head trial of the two marketed products. Source 1 Source 2
A person considering a change to prescribed care needs the actual product and the prescriber’s instructions. The Tri-Luma review illustrates another reason to preserve full formula identity: a combination prescription should not be reduced to whichever single ingredient is most familiar.
The route is part of what is being compared
The official Rx material directs the reader toward professional care, whereas the Fx page presents a retail cosmetic offer. Those routes involve different questions. A retail add-to-cart control does not establish prescription eligibility, and an educational Rx page does not confirm a clinician’s decision, a dispensing pharmacy or a delivered order. Source 1 Source 2
We did not complete an intake, submit health information or obtain a personalized quote. The review therefore cannot promise access, approval or a turnaround time. Keeping the route explicit is more useful than calling both products simply available online and leaving the reader to discover the difference later. The Likeness provider review offers a separate example of why consultation and billing details belong beside the formula.
The observed $125 belongs to Clear Fx
The Clear Fx page displayed $125 when checked. That amount should stay attached to the named cosmetic product and the selected listing. It is not a verified price for prescription Clear Rx, a consultation, a combined regimen or the complete cost of a course of care. Source 2
For an Rx purchase, ask what the quote includes: assessment, product, quantity, dispensing and any shipping or follow-up charges. The cost guide helps keep those components visible. We have not established insurance coverage, a recurring charge or the number of containers a particular plan would require.
Read cosmetic claims within their proper boundary
Clear Fx is positioned around the appearance of skin tone and discoloration. FDA guidance explains the boundary between cosmetic claims and claims that a product treats disease or affects body structure or function. A manufacturer’s cosmetic description should not be expanded into an unverified statement that the product treats a diagnosed condition. Source 2 Source 3
This review also does not infer regulatory approval from the brand name, a professional sales route or the existence of published product information. Any approval statement would need to be established for the specific product and indication. That question is separate from whether a page contains an ingredient declaration.
The label matters more than a familiar collection name
Before using either record, check the current container, complete ingredients and supplied directions. Names, collection pages and retailer descriptions can be abbreviated, and an older article may concern a different formula. We did not inspect a dispensed package, so the current label remains an important check at the point of care or purchase. Source 1 Source 2
Avoid building a regimen from this comparison alone. The dark-spot routine guide provides general reading context, while decisions about a prescription’s duration, combinations or monitoring belong with the treating professional. This article does not provide an individualized application schedule.
A useful comparison keeps the unresolved fields visible
For Clear Rx, the unresolved purchase fields include the actual prescribed product and all-in quote. For Clear Fx, the recorded $125 retail offer still needs current quantity, shipping and seller terms checked at checkout. Keeping these gaps visible prevents a product name from doing the work of evidence that has not been gathered.
The result is a more accurate pair of records, rather than a claim that one formula is universally better. Similar names can support very different decisions. Use the full product identity, the relevant ingredient declaration and the correct buying route together before interpreting a price or deciding what further advice is needed.
THE SOURCE MATERIAL
Read the originals.
Source retrieval dates appear with each record below. A commercial page supports offer details; it does not independently validate the treatment claims.
- Dark Spot Lightener & Corrector Cream | Obagi Nu-Derm® Rx ↗
Public source checked for this editorial review; no product-use or transaction test.
Source checked: 2026-10-14
- Skin Brightening Cream | Obagi Clear Fx ↗
Public source checked for this editorial review; no product-use or transaction test.
Source checked: 2026-10-14
- Cosmetics Labeling Claims | FDA ↗
Public source checked for this editorial review; no product-use or transaction test.
Source checked: 2026-10-14